Lixte Biotechnology Holdings, Inc. (LIXT)
USD 1.91
(-19.75%)
USD 1.91
(-19.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.29 Million | -4.61 Million | -4.14 Million | -2.13 Million | -1.67 Million | -1.51 Million |
| Net Income | -5.08 Million | -6.31 Million | -6.72 Million | -3.26 Million | -2.44 Million | -2.13 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 773.2 Thousand | 1.54 Million | 2.59 Million | 1.25 Million | 748.65 Thousand | 785.61 Thousand |
| Change in working capital | 20.56 Thousand | 154.75 Thousand | -13.44 Thousand | -117.88 Thousand | 17.54 Thousand | -163.51 Thousand |
| Other non-cash items | 847.17 Thousand | 1.54 Million | 2.56 Million | 1.19 Million | 814.68 Thousand | 902.43 Thousand |
| Investing Cash Flow | 3.13 Million | 5.14 Million | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | 5.14 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 3.13 Million | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.14 Million | 5.14 Million | 3.89 Million | 4.6 Million | - | 4.47 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -24.7 Thousand |
| Common Stock Issuance | 3.14 Million | 5.14 Million | 3.89 Million | 4.6 Million | - | 4.5 Million |
| Other Financing Activities | 3.14 Million | 5141.38 | -10.46 Thousand | 4601.82 | - | -21.7 Thousand |
| Accounts receivables | - | - | - | 14.36 Thousand | -14.36 Thousand | - |
| Accounts payables | -73.97 Thousand | 3799.00 | 35.67 Thousand | 46.74 Thousand | -51.66 Thousand | -116.82 Thousand |
| Inventory | - | - | - | -14.36 Thousand | 14.36 Thousand | - |
| Other working capital | 94.53 Thousand | 150.95 Thousand | -49.11 Thousand | -164.62 Thousand | 69.2 Thousand | -46.69 Thousand |
| Cash at beginning of period | 5.35 Million | 4.82 Million | 5.06 Million | 2.59 Million | 4.27 Million | 1.3 Million |
| Cash at end of period | 4.2 Million | 5.35 Million | 4.82 Million | 5.06 Million | 2.59 Million | 4.27 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -3.13 Million | -5.14 Million | - | - | - | - |
| Net cash flow / Change in cash | -1.14 Million | 529.64 Thousand | -245.52 Thousand | 2.47 Million | -1.67 Million | 2.96 Million |
| Free Cash Flow | -4.29 Million | -4.61 Million | -4.14 Million | -2.13 Million | -1.67 Million | -1.51 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.01 Million | -971.32 Thousand | -5.08 Million | -1.03 Million | -1.01 Million | -1.66 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 130.69 Thousand | 102.92 Thousand | 773.2 Thousand | 104.05 Thousand | 112.1 Thousand | 280.06 Thousand |
| Change in working capital | 61.18 Thousand | 79.17 Thousand | 20.56 Thousand | 26.07 Thousand | -37.73 Thousand | 212.91 Thousand |
| Other non-cash items | 245.97 Thousand | 12.99 Thousand | 847.17 Thousand | -1.00 | 257.46 Thousand | 137.16 Thousand |
| Investing Cash Flow | - | - | 3.13 Million | 3.13 Million | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 3.13 Million | 3.13 Million | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 3.14 Million | - | 3.13 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 3.14 Million | -3.14 Million | 3.13 Million | - |
| Other Financing Activities | - | - | 3.14 Million | 3.14 Million | 3137.08 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -115.28 Thousand | 89.92 Thousand | -73.97 Thousand | -65.38 Thousand | -145.35 Thousand | 142.89 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 176.47 Thousand | -10.75 Thousand | 94.53 Thousand | 91.45 Thousand | 107.62 Thousand | 70.01 Thousand |
| Cash at beginning of period | 3.41 Million | 4.2 Million | 5.35 Million | 5.1 Million | 2.91 Million | 4.08 Million |
| Cash at end of period | 2.59 Million | 3.41 Million | 4.2 Million | 4.2 Million | 5.1 Million | 2.91 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -3.13 Million | - | - | - |
| Net cash flow / Change in cash | -819.04 Thousand | -789.22 Thousand | -1.14 Million | -902.12 Thousand | 2.19 Million | -1.17 Million |
| Free Cash Flow | -819.04 Thousand | -789.22 Thousand | -4.29 Million | -902.12 Thousand | -944.38 Thousand | -1.17 Million |
SEIGF
MAMTF
ARION-SDB
002932
603617
0411